People differ from one another in millions of ways. For starters, there is eye color, hair color, body build, and tendencies toward certain diseases and conditions. We know that genes determine these differences. Now, we also are learning that genes affect how our bodies respond to disease. Through the study of genetic links between patients and chronic diseases, Geisinger Health System researchers are hoping to gain a better understanding of how to prevent, diagnose and treat these diseases.
A new program at Geisinger called MyCode is capitalizing on the health system’s unique ability to utilize its integrated infrastructure to link genomic information with one of the nation's most advanced electronic health record (EHR) systems and fastest growing biobanks. The result is a powerful tool that is the bridge to Geisinger's personalized medicine program – an initiative that promises to ultimately re-engineer the paradigm of healthcare from reactive to predictive and, with the help of researchers and physicians, engage patients in their personal health and wellness.
Geisinger patients learn about MyCode at Geisinger Medical Group sites and about 90 percent choose to participate. With written consent, participants agree to provide a deoxyribonucleic acid (DNA) sample – chemical material that is inherited and extracted from a blood sample - at their next scheduled blood draw. From there, the sample is linked with EHR information and routed to the system’s biobank for quick researcher access.
Since launching the MyCode pilot program two years ago, researchers have collected 20,000 DNA samples – proportionately more samples than from any other biobanking facility nationwide. Samples generally fall into two groups: those from patients seeking general health and wellness care from their family physicians and those from patients seeking specialty medical care, such as bariatric surgery.
These samples are helping Geisinger researchers gain critical insight into patients’ risk of chronic health conditions, such as abdominal aortic aneurysms (AAA), severe asthma, depression, obesity, familial ureterocoele, digoxin/phenytoin toxicity, overactive bladder syndrome and various pain conditions.
“This information will ultimately improve health by motivating people to make positive lifestyle changes, such as exercising, eating healthy, quitting smoking as well as decisions to seek further medical evaluation and preventive strategies,” said Geisinger Center for Health Research Director Walter “Buzz” Stewart, Ph.D., M.P.H.
A number of safeguards protect the privacy of participants’ genetic and EHR information. Confidentiality and subject anonymity are strictly maintained by de-identifying the samples. Samples are assigned specific identification numbers, encoded, encrypted and entered into a secure database. A governance board – with Geisinger and non-Geisinger representation - meets several times a year to audit the process.
“The goal of MyCode is to translate genetic data into specific knowledge about a disease that is clinically relevant and will enhance patient care,” said Glenn Gerhard, M.D., staff scientist and director of Geisinger’s Genomics Core. “Geisinger’s integrated healthcare delivery system, geography, as well as its electronic health record, biobank, lab, data, and basic science and population-based research programs, make this an outstanding environment for discovery."
“MyCode aims to discover genes that increase a person’s risk of chronic disease and help us understand why people respond differently to treatments,” explained Weis Center for Research Director David Carey, Ph.D. “The more we know about the causes of disease, the greater our ability to provide more effective treatment and, ultimately, prevent disease from occurring.”
According to Carey, by matching genes with a comprehensive profile of a specific chronic condition, researchers are able to study groups of patients with similar signs and symptoms and begin to predict and understand how they will respond to a specific treatment or medication.
“This project provides the opportunity to move genetics from the laboratory directly to patient care,” explained Stewart. “MyCode is driving research that promises to improve the health and healthcare of patients nationwide.”About Geisinger Health System
Patricia Urosevich | Newswise Science News
Further reports about: > DNA > Depression > MyCode Project > Personalized Medicine > abdominal aortic aneurysms > biobanking facility > body build > chronic disease > chronic diseases > deoxyribonucleic acid (DNA) sample > digoxin/phenytoin toxicity > eye color > genes > genomic information > hair color > overactive bladder syndrome
Collagen nanofibrils in mammalian tissues get stronger with exercise
14.12.2018 | University of Illinois College of Engineering
New discoveries predict ability to forecast dementia from single molecule
12.12.2018 | UT Southwestern Medical Center
The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.
Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.
Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...
Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
14.12.2018 | Power and Electrical Engineering
14.12.2018 | Physics and Astronomy
14.12.2018 | Physics and Astronomy